Obesity drugs such as Wegovy and Zepbound could become a significant part of American healthcare due to their effects on heart health, according to a new study. The study shows that Wegovy reduced the risk of major cardiac events by 20% among participants. This could lead to an increased number of patients using these drugs, despite their high cost and limited availability. However, these drugs’ long-term safety and continued supply issues remain unanswered.
DataBreaches.Net Wishes You a Happy Thanksgiving!
Alright then, gather ’round everyone, let’s have a chinwag about something quite important, shall we? I know, I know… it’s a bit more serious than
